glutathione and thioredoxin antioxidant pathways reductases Thioredoxin Reductase 2 - an
Description
10.1016/j.clnesp.2022.03.031 242
In some embodiments, the otic formulation or composition comprises between about 0.01% to about 15% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Johannsson, G
13 (8) e1006964
Overall, multiple factors involved in the regulation and synthesis of amino acids could be subject to potential therapeutic intervention
